Documents (76,216) JSON TSV

source DB	source ID	text	size	updated at	# proj.	# Ann.	updated_at
PMC	7381711	Heparin as a therapy for COVID-19: current evidence and future possibilities HEPARIN IN COVID-19 Ab	21.1 KB	2020-11-19	18	18	2021-01-31
PMC	7301188	D-Dimer and Prothrombin Time Are the Significant Indicators of Severe COVID-19 and Poor Prognosis A	23.6 KB	2020-10-13	19	17	2021-01-31
PMC	7309518	Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic disease More	24 KB	2020-09-27	18	16	2021-01-31
PMC	7441777	Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2 via RNA‐dependent	50.4 KB	2020-09-27	18	16	2021-01-31
PMC	7358770	Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vacci	38.5 KB	2020-10-14	20	15	2021-01-31
PMC	7560789	Detection of Invasive Pulmonary Aspergillosis in COVID-19 with Nondirected BAL To the Editor: Invas	10.5 KB	2020-11-19	16	14	2021-01-31
PMC	7435837	Layer-by-Layer Nanocoating of Antiviral Polysaccharides on Surfaces to Prevent Coronavirus Infection	50.9 KB	2020-09-27	18	14	2021-01-31
PMC	7265874	COVID-19-associated invasive pulmonary aspergillosis To the Editor: Since March 2020, following in	10.1 KB	2020-09-27	17	13	2021-01-31
PMC	7247483	Fungal antigenemia in patients with severe Coronavirus disease 2019 (COVID-19): The facts and challe	4.95 KB	2020-09-27	18	11	2021-01-31
PMC	7560808	Injury to the Endothelial Glycocalyx in Critically Ill Patients with COVID-19 To the Editor: Severe	12.9 KB	2020-11-19	15	10	2021-01-31